check_circleStudy Completed

Biological Availability, Postmenopause, Hormone Replacement Therapy

Bayer Identifier:

91130

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to compare the bioavailability of estriol after single oral administration of the two estriol-containing preparations in postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
24
Trial Dates
January 2003 - February 2003
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Estriol (E3)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Open-label, randomized, two-way crossover study to compare the bioavailability of estriol after single oral administration of the two estriolcontaining preparations Estriol 2 mg JENAPHARM® and a microcrystalline estriol suspension in 24 healthy postmenopausal volunteers
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.